Five takeaways on progress altering the Parkinson’s therapeutic landscape, from day two of The Michael J. Fox Foundation’s ...

Neurology residents explore Parkinson's care, research advances and career opportunities at the 2026 MDS-PAS Movement Disorders School.

Managing Parkinson’s medications can be a complex task no matter where you or your loved one are in your journey with PD. When is it best to start or adjust medication? How much should you take? How ...

The Michael J. Fox Foundation for Parkinson’s Research invites you to our free educational event for people with Parkinson’s and their loved ones. Join us in Washington, D.C. on October 24, 2026 at ...

Dr. Shill received her medical degree from the University of Arizona, College of Medicine. She completed her internship at St. Joseph’s Hospital and Medical Center in internal medicine. Dr. Shill ...

The U.S. Food and Drug Administration has approved AbbVie’s Vyalev, an infusion-based Parkinson’s treatment that is shown to increase “on” time (when symptoms are well controlled) by providing a ...

The U.S. Department of Veterans Affairs (VA) recently announced they will put into effect legislation to provide health care and benefits for veterans who served in the military in Southwest Asia with ...

Today, our founder Michael J. Fox was awarded the Presidential Medal of Freedom, the nation’s highest civilian honor. The award recognizes individuals who have made exemplary contributions to the ...

People with Parkinson’s disease (PD) often ask about complementary medicine and alternative therapies that might work for different symptoms. Although we’ve heard from some people in the community ...

The U.S. Food and Drug Administration (FDA) has approved tavapadon, a once-daily oral medication for the treatment of motor symptoms of Parkinson’s disease. Tavapadon, which will be sold under the ...

Buckle your seatbelts — we’re thrilled to travel back in time alongside our intrepid founder who’s written his fifth book, due out October 14 from Flatiron Books. People.com got the scoop on what ...

There’s a lot of promise and momentum in Parkinson’s drug development. We started 2024 with the potential for four new Parkinson’s medications to gain approval in the United States. These treatments ...